PHIBRO ANIMAL HEALTH CORP
PAHCNasdaq
$33.31
↓ -3.5%Jul 17 close · end-of-day
Price
1Y↑ +10.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.4B
Enterprise Value
$1.9B
P/E
14.2
P/S
0.9
P/B
3.8
EV/EBITDA
8.3
PEG
—
FCF Yield
—
Dividend Yield
1.4%
Revenue (TTM)
$1.5B
Net Income (TTM)
$95.2M
Free Cash Flow (TTM)
—
Gross Margin
32.5%
Operating Margin
12.0%
Net Margin
6.3%
ROE
26.3%
ROIC
14.7%
Debt / Equity
1.7
Net Cash
-$543.1M
Return 1Y
+13.5%
Company profile
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases.
- CEO
- Jack C. Bendheim
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 1,860
- Headquarters
- New Jersey
- Website
- pahc.com
Management & directors
- Bendheim JackPresident and CEO
- David GlennChief Financial Officer
- Andolino AnthonySee Remarks
- Bendheim Daniel MExec. VP, Corporate Strategy
- Escudero Lisa AnnSee Remarks
- Miller Larry LeeChief Operating Officer
- Weinstein JudithSee Remarks
Roles derived from SEC Form 4 filings.
Earnings
PAHC Q3 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$383.5M↑ +10.3%
Diluted EPS$0.59↑ +15.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $833.4M | $942.3M | $977.9M | $1.0B | $1.3B |
| Gross profit | $271.4M | $285.4M | $298.2M | $313.1M | $399.9M |
| Operating income | $74.9M | $79.0M | $71.8M | $53.3M | $110.5M |
| Net income | $54.4M | $49.2M | $32.6M | $2.4M | $48.3M |
| Diluted EPS | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 |
| Operating cash flow | $48.3M | $31.6M | $13.3M | $87.6M | $80.1M |
| Free cash flow | — | — | — | — | — |
| Gross margin | 32.6% | 30.3% | 30.5% | 30.8% | 30.9% |
| Operating margin | 9.0% | 8.4% | 7.3% | 5.2% | 8.5% |
| Net margin | 6.5% | 5.2% | 3.3% | 0.2% | 3.7% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $273.2M | $260.4M | $309.3M | $347.8M | $378.7M | $363.9M | $373.9M | $383.5M |
| Gross profit | $87.2M | $83.5M | $101.9M | $104.6M | $110.0M | $119.8M | $132.7M | $125.7M |
| Operating income | $18.4M | $17.7M | $25.5M | $33.5M | $33.7M | $51.3M | $50.3M | $44.7M |
| Net income | $752,000.00 | $7.0M | $3.2M | $20.9M | $17.2M | $26.5M | $27.5M | $24.0M |
| Diluted EPS | $0.02 | $0.17 | $0.08 | $0.51 | $0.43 | $0.65 | $0.67 | $0.59 |
| Operating cash flow | $28.4M | $12.6M | $3.1M | $43.2M | $21.3M | $9.3M | $19.4M | $16.2M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 31.9% | 32.1% | 32.9% | 30.1% | 29.0% | 32.9% | 35.5% | 32.8% |
| Operating margin | 6.7% | 6.8% | 8.3% | 9.6% | 8.9% | 14.1% | 13.5% | 11.6% |
| Net margin | 0.3% | 2.7% | 1.0% | 6.0% | 4.5% | 7.3% | 7.3% | 6.3% |
Company news
Jul 9, 2026
- 11d agoPAHC or LZAGY: Which Is the Better Value Stock Right Now?finance.yahoo.com
- 11d agoPhibro Animal Health (PAHC) Leaves Russell Indexes, Is The Stock A Bargain?finance.yahoo.com
- 11d agoPhibro Animal Health (PAHC) Stock Looks Reasonable On Value But Stretched After 138% Gainfinance.yahoo.com
- 11d agoPhibro Animal Health (PAHC) Stock Loses Russell Index Spots And Investor Visibilityfinance.yahoo.com
Jul 6, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-29 | CORCORAN E THOMAS | Buy | 10,000 | $31.77 | $317,700.00 | filing |
| 2026-05-07 | BENDHEIM JACK· President and CEO | Sale | 2,029 | $49.19 | $99,815.03 | filing |
| 2026-05-07 | BENDHEIM JACK· President and CEO | Sale | 1,350 | $47.59 | $64,247.58 | filing |
| 2026-05-07 | BENDHEIM JACK· President and CEO | Sale | 1,149 | $48.31 | $55,505.20 | filing |
| 2026-05-06 | BENDHEIM JACK· President and CEO | Sale | 5,634 | $57.18 | $322,125.08 | filing |
| 2026-05-06 | BENDHEIM JACK· President and CEO | Sale | 1,406 | $58.13 | $81,724.73 | filing |
| 2026-05-05 | BENDHEIM JACK· President and CEO | Sale | 6,264 | $55.73 | $349,070.80 | filing |
| 2026-05-05 | BENDHEIM JACK· President and CEO | Sale | 776 | $56.37 | $43,739.24 | filing |
| 2026-04-30 | BENDHEIM JACK· President and CEO | Sale | 5,805 | $52.65 | $305,617.58 | filing |
| 2026-04-30 | BENDHEIM JACK· President and CEO | Sale | 1,235 | $53.32 | $65,847.61 | filing |
| 2026-04-29 | BENDHEIM JACK· President and CEO | Sale | 4,002 | $52.70 | $210,907.40 | filing |
| 2026-04-29 | BENDHEIM JACK· President and CEO | Sale | 3,038 | $53.21 | $161,645.30 | filing |
| 2026-04-28 | BENDHEIM JACK· President and CEO | Sale | 4,591 | $56.06 | $257,374.67 | filing |
| 2026-04-28 | BENDHEIM JACK· President and CEO | Sale | 1,652 | $55.10 | $91,018.59 | filing |
| 2026-04-28 | BENDHEIM JACK· President and CEO | Sale | 797 | $56.69 | $45,181.61 | filing |
| 2026-04-23 | BENDHEIM JACK· President and CEO | Sale | 6,619 | $54.07 | $357,856.90 | filing |
| 2026-04-23 | BENDHEIM JACK· President and CEO | Sale | 421 | $54.56 | $22,969.00 | filing |
| 2026-04-22 | BENDHEIM JACK· President and CEO | Sale | 7,040 | $54.29 | $382,184.70 | filing |
| 2026-04-21 | BENDHEIM JACK· President and CEO | Sale | 5,415 | $56.17 | $304,136.72 | filing |
| 2026-04-21 | BENDHEIM JACK· President and CEO | Sale | 1,625 | $55.35 | $89,943.91 | filing |
| 2026-04-16 | BENDHEIM JACK· President and CEO | Sale | 5,190 | $54.56 | $283,141.49 | filing |
| 2026-04-16 | BENDHEIM JACK· President and CEO | Sale | 1,850 | $54.88 | $101,520.42 | filing |
| 2026-04-16 | BENDHEIM JACK· President and CEO | C | 100,000 | $0.00 | $0.00 | filing |
| 2026-04-15 | BENDHEIM JACK· President and CEO | Sale | 3,618 | $57.21 | $206,985.42 | filing |
| 2026-04-15 | BENDHEIM JACK· President and CEO | Sale | 2,623 | $56.27 | $147,593.85 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.